These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 20381276)
1. Contrast enhanced MR imaging of female pelvic cancers: established methods and emerging applications. Punwani S Eur J Radiol; 2011 Apr; 78(1):2-11. PubMed ID: 20381276 [TBL] [Abstract][Full Text] [Related]
2. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Punwani S Eur J Radiol; 2011 Apr; 78(1):21-9. PubMed ID: 20801592 [TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study. Mendichovszky IA; Cutajar M; Gordon I Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588 [TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced breast MR imaging. Moon M; Cornfeld D; Weinreb J Magn Reson Imaging Clin N Am; 2009 May; 17(2):351-62. PubMed ID: 19406363 [TBL] [Abstract][Full Text] [Related]
5. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
6. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. Xu PJ; Yan FH; Wang JH; Lin J; Ji Y J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186 [TBL] [Abstract][Full Text] [Related]
8. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. Scattoni V; Da Pozzo LF; Colombo R; Nava L; Rigatti P; De Cobelli F; Vanzulli A; Del Maschio A J Urol; 1996 May; 155(5):1594-9. PubMed ID: 8627831 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of gadolinium-enhanced T1-weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancer. Jao SY; Yang BY; Weng HH; Yeh CH; Lee LW Colorectal Dis; 2010 Nov; 12(11):1139-48. PubMed ID: 19548900 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [TBL] [Abstract][Full Text] [Related]
11. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting. Radjenovic A; Ridgway JP; Smith MA Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029 [TBL] [Abstract][Full Text] [Related]
12. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis. Sala E; Rockall A; Rangarajan D; Kubik-Huch RA Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230 [TBL] [Abstract][Full Text] [Related]
14. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences]. Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777 [TBL] [Abstract][Full Text] [Related]
15. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033 [TBL] [Abstract][Full Text] [Related]
16. [Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media]. Barile A; Caulo M; Zugaro L; Di Cesare E; Gallucci M; Masciocchi C Radiol Med; 2001 Jun; 101(6):444-55. PubMed ID: 11479441 [TBL] [Abstract][Full Text] [Related]
17. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563 [TBL] [Abstract][Full Text] [Related]
18. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior]. Doringer E; Joos H; Forstner R; Schmoller H Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149 [TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the prostate. Bonekamp D; Macura KJ Top Magn Reson Imaging; 2008 Dec; 19(6):273-84. PubMed ID: 19512849 [TBL] [Abstract][Full Text] [Related]
20. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media]. Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]